/Companies

Cancer Genetics

Rutherford, US · Delaware corporation

Find your way into Cancer Genetics

Sign up to see every warm intro you have to Cancer Genetics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cancer Genetics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

RS
Raju S.K. ChagantiFounder
PL
Panna L. SharmaExecutive
ES
Edward SitarExecutive

Board

JP
John PappajohnBoard director
HM
Howard McLeodBoard director
FG
Franklyn G. PrendergastBoard director
MJ
Michael J. WelshBoard director
GH
Geoffrey HarrisBoard director
EC
Edmund CannonBoard director

Reported raises · per SEC filings

Form D private placements

$26.5M disclosed across 4 rounds · 2016–2021

▶$10MraisedFeb 2021 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John A. RobertsExecutive Officer
  • Howard McLeodDirector
  • Geoffrey HarrisDirector
  • Franklyn G. PrendergastDirector
  • Edmund CannonDirector
Offering amount
$10M
Amount sold
$10M
Sales commissions
$775K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedMar 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Franklyn G. PrendergastDirector
  • Howard McLeodDirector
  • Geoffrey HarrisDirector
  • Michael J. WelshDirector
  • John A. RobertsExecutive Officer
  • Edmund CannonDirector
  • Panna L. SharmaExecutive Officer, Director
  • Raju S.K. ChagantiDirector
  • John PappajohnDirector
Offering amount
$6M
Amount sold
$6M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.5MraisedDec 2016 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael J. WelshDirector
  • Raju S.K. ChagantiExecutive Officer, Director
  • Geoffrey HarrisDirector
  • Howard McLeodDirector
  • John PappajohnDirector
  • Franklyn G. PrendergastDirector
  • John A. RobertsExecutive Officer
  • Edward SitarExecutive Officer
  • Edmund CannonDirector
  • Panna L. SharmaExecutive Officer, Director
Offering amount
$5.5M
Amount sold
$5.5M
Sales commissions
$385K
Placement agents
H.C. WainWright & Co., LLC
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedMay 2016 · 41 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Raju S.K. ChagantiExecutive Officer, Director
  • Howard McLeodDirector
  • Franklyn G. PrendergastDirector
  • Panna L. SharmaExecutive Officer, Director
  • Edward SitarExecutive Officer
  • John PappajohnDirector
  • Michael J. WelshDirector
  • Geoffrey HarrisDirector
  • Edmund CannonDirector
Offering amount
$5M
Amount sold
$5M
Sales commissions
$350K
Placement agents
H.C. WainWright & Co., LLC
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Cancer Genetics?
Cancer Genetics was founded by Raju S.K. Chaganti.
How much funding has Cancer Genetics raised?
Cancer Genetics has disclosed $26.5M raised across 4 rounds.
Where is Cancer Genetics headquartered?
Cancer Genetics is headquartered in Rutherford, US.